Intense exercise induces the degradation of adenine nucleotide and purine nucleotide synthesis via de novo pathway in the rat liver

被引:10
|
作者
Mikami, T
Kitagawa, J
机构
[1] Nippon Med Coll, Dept Hlth & Sports Sci, Nakahara Ku, Kawasaki, Kanagawa 2110063, Japan
[2] Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, Tokyo 1528552, Japan
关键词
exercise; liver; purine nucleotide; de novo synthesis; salvage pathway;
D O I
10.1007/s00421-005-0106-4
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The purpose of this study was to investigate the influence of intense exercise on the metabolism of adenine nucleotides in the liver. In the first experiment, to determine the degradation of adenine nucleotides, hepatic adenine nucleotides of rats were labeled by an intraperitoneal administration of N-15-labeled adenine the day before treadmill running to exhaustion. In the second experiment, to determine the de novo synthesis of purine nucleotides after intense exercise, C-14-glycine was intraperitoneally administered to rats performing intense running on a treadmill. In the first experiment, hepatic levels of ATP and total adenine nucleotides showed a reduction immediately after exercise. In contrast, hepatic levels of AMP, adenosine, hypoxanthine and uric acid showed an increase immediately after exercise. The hepatic N-15 level continued to decline during the recovery period after exercise. Urinary excretion of N-15-urate was 40% higher in the exercised rats than in the control rats. In the second experiment, the radioactivity of C-14 detected in the fraction of hepatic urate and allantoin was approximately 300% higher in the exercised rats than in the control rats. C-14-radioactivity that excreted into urine as urate and allantoin was approximately 200% higher in the exercised rats. Intense exercise led to the degradation of hepatic adenine nucleotides, which were not utilized for the re-synthesis of nucleotide and further degraded to hypoxanthine or uric acid. Intense exercise induced the synthesis of purine nucleotides in the liver via a de novo pathway and these synthesized nucleotides were also degraded to nucleosides and excreted into urine.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 47 条
  • [41] Tumor-targeting with novel non-benzoyl 6-substituted pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis
    Cherian, Christina
    Wang, Yiqiang
    Mitchell-Ryan, Shermaine
    Orr, Steven
    Hou, Zhanjun
    Gangjee, Aleem
    Matherly, Larry H.
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [42] Tumor-targeting with novel dual-targeted 6-substituted thieno[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α, and inhibition of de novo purine nucleotide biosynthesis
    Wallace-Povirk, Adrianne
    Tong, Nian
    O'Connor, Carrie
    Hou, Zhanjun
    Gangjee, Aleem
    Matherly, Larry
    Zhou, Xilin
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [43] DE-NOVO PURINE NUCLEOTIDE SYNTHESIS IN TOTAL PERIPHERAL-BLOOD LYMPHOCYTES FROM PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) (VOL 22, PG 241S, 1994)
    DISPENSA, E
    CARLUCCI, F
    CONSOLMAGNO, E
    GALIENI, P
    LEONCINI, R
    PIZZICHINI, M
    TABUCCHI, A
    PAGANI, R
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (04) : 1105 - 1105
  • [44] Tumor-Targeting with Novel Non-Benzoyl 6-Substituted Straight Chain Pyrrolo[2,3-d]pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and Inhibition of de Novo Purine Nucleotide Biosynthesis
    Wang, Yiqiang
    Cherian, Christina
    Orr, Steven
    Mitchell-Ryan, Shermaine
    Hou, Zhanjun
    Raghavan, Sudhir
    Matherly, Larry H.
    Gangjee, Aleem
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8684 - 8695
  • [45] Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis
    Ravindra, Manasa
    Wallace-Povirk, Adrianne
    Karim, Mohammad A.
    Wilson, Mike R.
    O'Connor, Carrie
    White, Kathryn
    Kushner, Juiwanna
    Polin, Lisa
    George, Christina
    Hou, Zhanjun
    Matherly, Larry H.
    Gangjee, Aleem
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 2027 - 2040
  • [46] Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
    Golani, Lalit K.
    Wallace-Povirk, Adrianne
    Deis, Siobhan M.
    Wong, Jennifer
    Ke, Jiyuan
    Gu, Xin
    Raghavan, Sudhir
    Wilson, Mike R.
    Li, Xinxin
    Poling, Lisa
    de Waal, Parker W.
    White, Kathryn
    KushnerP, Juiwanna
    O'Connor, Carrie
    Hou, Zhanjun
    Xu, H. Eric
    Melcher, Karsten
    Dann, Charles E., III
    Matherly, Larry H.
    Gangjee, Aleem
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (17) : 7856 - 7876
  • [47] Tumor-targeting with novel pyridyl 6-substituted pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor (FR) α and the proton-coupled folate transporter (PCFT) and inhibition of de novo purine nucleotide biosynthesis
    Cherian, Christina
    Wang, Lei
    Wallace, Adrianne
    Orr, Steven
    Hou, Zhanjun
    Gangjee, Aleem
    Matherly, Larry H.
    [J]. CANCER RESEARCH, 2014, 74 (19)